ArticleVaccines2025

The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial.

Lili Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.